

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | dopamine biosynthetic process (GO:0042416) | 4.77635121 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.76146145 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 4.76146145 |
| 4 | drug transmembrane transport (GO:0006855) | 4.73593794 |
| 5 | presynaptic membrane organization (GO:0097090) | 4.61400590 |
| 6 | dopamine transport (GO:0015872) | 4.55072140 |
| 7 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.42586677 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.40731898 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 4.40731898 |
| 10 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.31369183 |
| 11 | catecholamine biosynthetic process (GO:0042423) | 4.07076048 |
| 12 | catechol-containing compound biosynthetic process (GO:0009713) | 4.07076048 |
| 13 | glycerophospholipid catabolic process (GO:0046475) | 3.96412919 |
| 14 | inositol phosphate catabolic process (GO:0071545) | 3.93719532 |
| 15 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.84942217 |
| 16 | inositol phosphate dephosphorylation (GO:0046855) | 3.84942217 |
| 17 | urate metabolic process (GO:0046415) | 3.82190580 |
| 18 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.70741874 |
| 19 | catecholamine transport (GO:0051937) | 3.68419245 |
| 20 | drug transport (GO:0015893) | 3.67729533 |
| 21 | toxin metabolic process (GO:0009404) | 3.67314861 |
| 22 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.67240092 |
| 23 | respiratory chain complex IV assembly (GO:0008535) | 3.66960180 |
| 24 | indolalkylamine metabolic process (GO:0006586) | 3.65983115 |
| 25 | alkaloid metabolic process (GO:0009820) | 3.64044764 |
| 26 | aromatic amino acid family catabolic process (GO:0009074) | 3.59417995 |
| 27 | presynaptic membrane assembly (GO:0097105) | 3.57384938 |
| 28 | respiratory electron transport chain (GO:0022904) | 3.54391347 |
| 29 | electron transport chain (GO:0022900) | 3.51598036 |
| 30 | organic cation transport (GO:0015695) | 3.45658877 |
| 31 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.45058439 |
| 32 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.45058439 |
| 33 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.43813408 |
| 34 | ATP synthesis coupled proton transport (GO:0015986) | 3.43813408 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 3.35345141 |
| 36 | monoamine transport (GO:0015844) | 3.33916676 |
| 37 | neurotransmitter biosynthetic process (GO:0042136) | 3.32750836 |
| 38 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.30947296 |
| 39 | serotonin metabolic process (GO:0042428) | 3.30137264 |
| 40 | positive regulation of amino acid transport (GO:0051957) | 3.29632496 |
| 41 | phenol-containing compound catabolic process (GO:0019336) | 3.28769553 |
| 42 | cytochrome complex assembly (GO:0017004) | 3.25077258 |
| 43 | transferrin transport (GO:0033572) | 3.23881791 |
| 44 | trivalent inorganic cation transport (GO:0072512) | 3.16667355 |
| 45 | ferric iron transport (GO:0015682) | 3.16667355 |
| 46 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.16533841 |
| 47 | indole-containing compound metabolic process (GO:0042430) | 3.15940780 |
| 48 | Golgi transport vesicle coating (GO:0048200) | 3.11879972 |
| 49 | COPI coating of Golgi vesicle (GO:0048205) | 3.11879972 |
| 50 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.11441839 |
| 51 | regulation of glucokinase activity (GO:0033131) | 3.10627374 |
| 52 | regulation of hexokinase activity (GO:1903299) | 3.10627374 |
| 53 | dendritic spine morphogenesis (GO:0060997) | 3.09582620 |
| 54 | insulin secretion (GO:0030073) | 3.07859583 |
| 55 | succinate metabolic process (GO:0006105) | 3.07662632 |
| 56 | glycoside metabolic process (GO:0016137) | 3.07111069 |
| 57 | mannosylation (GO:0097502) | 3.06166802 |
| 58 | dopamine metabolic process (GO:0042417) | 3.04864602 |
| 59 | behavioral response to nicotine (GO:0035095) | 3.04134622 |
| 60 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.03857135 |
| 61 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.03669709 |
| 62 | neurotransmitter metabolic process (GO:0042133) | 3.02227858 |
| 63 | primary amino compound metabolic process (GO:1901160) | 2.98828250 |
| 64 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.98768308 |
| 65 | regulation of dopamine metabolic process (GO:0042053) | 2.97096069 |
| 66 | regulation of catecholamine metabolic process (GO:0042069) | 2.97096069 |
| 67 | cysteine metabolic process (GO:0006534) | 2.96902853 |
| 68 | peptide hormone processing (GO:0016486) | 2.96218230 |
| 69 | phenol-containing compound biosynthetic process (GO:0046189) | 2.95174415 |
| 70 | drug catabolic process (GO:0042737) | 2.93356337 |
| 71 | aldehyde catabolic process (GO:0046185) | 2.93336340 |
| 72 | polyol catabolic process (GO:0046174) | 2.92108963 |
| 73 | glyoxylate metabolic process (GO:0046487) | 2.90170633 |
| 74 | synaptic vesicle exocytosis (GO:0016079) | 2.89246574 |
| 75 | cellular ketone body metabolic process (GO:0046950) | 2.88240616 |
| 76 | protein localization to cilium (GO:0061512) | 2.87037312 |
| 77 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.86945046 |
| 78 | NADH metabolic process (GO:0006734) | 2.86684394 |
| 79 | tyrosine metabolic process (GO:0006570) | 2.85890419 |
| 80 | neurotransmitter catabolic process (GO:0042135) | 2.85293767 |
| 81 | regulation of oxidative phosphorylation (GO:0002082) | 2.84790381 |
| 82 | coenzyme catabolic process (GO:0009109) | 2.81675121 |
| 83 | signal peptide processing (GO:0006465) | 2.80890978 |
| 84 | neurotransmitter secretion (GO:0007269) | 2.79461219 |
| 85 | protein complex biogenesis (GO:0070271) | 2.74243120 |
| 86 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.72258121 |
| 87 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.72258121 |
| 88 | exogenous drug catabolic process (GO:0042738) | 2.71368299 |
| 89 | endocrine pancreas development (GO:0031018) | 2.70827553 |
| 90 | lysine catabolic process (GO:0006554) | 2.70419008 |
| 91 | lysine metabolic process (GO:0006553) | 2.70419008 |
| 92 | tryptophan metabolic process (GO:0006568) | 2.70266609 |
| 93 | proline transport (GO:0015824) | 2.70149926 |
| 94 | phosphate ion transport (GO:0006817) | 2.70070343 |
| 95 | nitric oxide mediated signal transduction (GO:0007263) | 2.70048076 |
| 96 | lactate metabolic process (GO:0006089) | 2.69206162 |
| 97 | artery smooth muscle contraction (GO:0014824) | 2.69058299 |
| 98 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.68790087 |
| 99 | cerebellar Purkinje cell layer development (GO:0021680) | 2.67561129 |
| 100 | oxaloacetate metabolic process (GO:0006107) | 2.65649845 |
| 101 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.65481471 |
| 102 | proton transport (GO:0015992) | 2.64573399 |
| 103 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.63519767 |
| 104 | tryptophan catabolic process (GO:0006569) | 2.62977310 |
| 105 | indole-containing compound catabolic process (GO:0042436) | 2.62977310 |
| 106 | indolalkylamine catabolic process (GO:0046218) | 2.62977310 |
| 107 | hydrogen transport (GO:0006818) | 2.62710166 |
| 108 | positive regulation of peptide hormone secretion (GO:0090277) | 2.60953665 |
| 109 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.60590355 |
| 110 | detection of calcium ion (GO:0005513) | 2.60563940 |
| 111 | response to pheromone (GO:0019236) | 2.59925714 |
| 112 | synaptic vesicle maturation (GO:0016188) | 2.59571430 |
| 113 | regulation of neurotransmitter uptake (GO:0051580) | 2.59132207 |
| 114 | branched-chain amino acid metabolic process (GO:0009081) | 2.58978098 |
| 115 | short-chain fatty acid metabolic process (GO:0046459) | 2.58660276 |
| 116 | glutamate secretion (GO:0014047) | 2.58316786 |
| 117 | nitric oxide biosynthetic process (GO:0006809) | 2.58093802 |
| 118 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.56991464 |
| 119 | hydrogen ion transmembrane transport (GO:1902600) | 2.56539733 |
| 120 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.56363799 |
| 121 | positive regulation of peptide secretion (GO:0002793) | 2.55851456 |
| 122 | positive regulation of neurotransmitter transport (GO:0051590) | 2.55743368 |
| 123 | glutathione biosynthetic process (GO:0006750) | 2.55723233 |
| 124 | positive regulation of vesicle fusion (GO:0031340) | 2.55448032 |
| 125 | positive regulation of meiosis (GO:0045836) | 2.55246920 |
| 126 | positive regulation of insulin secretion (GO:0032024) | 2.55025786 |
| 127 | nucleobase catabolic process (GO:0046113) | 2.54190733 |
| 128 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.54148950 |
| 129 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.54131537 |
| 130 | neurofilament cytoskeleton organization (GO:0060052) | 2.53459947 |
| 131 | alanine transport (GO:0032328) | 2.53208279 |
| 132 | intraciliary transport (GO:0042073) | 2.51925937 |
| 133 | maternal behavior (GO:0042711) | 2.51267336 |
| 134 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.49389584 |
| 135 | NADH dehydrogenase complex assembly (GO:0010257) | 2.49389584 |
| 136 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.49389584 |
| 137 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.48386109 |
| 138 | protein localization to Golgi apparatus (GO:0034067) | 2.45807876 |
| 139 | phagosome maturation (GO:0090382) | 2.45574433 |
| 140 | regulation of mitochondrial translation (GO:0070129) | 2.45231851 |
| 141 | ER overload response (GO:0006983) | 2.44310475 |
| 142 | ketone body metabolic process (GO:1902224) | 2.43276941 |
| 143 | tricarboxylic acid metabolic process (GO:0072350) | 2.43234977 |
| 144 | glandular epithelial cell differentiation (GO:0002067) | 2.43030461 |
| 145 | neurotransmitter transport (GO:0006836) | 2.43024407 |
| 146 | axoneme assembly (GO:0035082) | 2.42638847 |
| 147 | righting reflex (GO:0060013) | 2.42039591 |
| 148 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.40975327 |
| 149 | peptide hormone secretion (GO:0030072) | 2.40499383 |
| 150 | gamma-aminobutyric acid transport (GO:0015812) | 2.38793073 |
| 151 | negative regulation of membrane potential (GO:0045837) | 2.37941211 |
| 152 | regulation of insulin secretion (GO:0050796) | 2.37415775 |
| 153 | neuromuscular process controlling posture (GO:0050884) | 2.36341693 |
| 154 | calcium ion-dependent exocytosis (GO:0017156) | 2.36034089 |
| 155 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.35845045 |
| 156 | neuronal action potential (GO:0019228) | 2.35597908 |
| 157 | calcium ion import (GO:0070509) | 2.35410260 |
| 158 | membrane repolarization during action potential (GO:0086011) | 2.35171345 |
| 159 | positive regulation of meiotic cell cycle (GO:0051446) | 2.34304376 |
| 160 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.33782556 |
| 161 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.33737589 |
| 162 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.33737589 |
| 163 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.31070251 |
| 164 | peptide secretion (GO:0002790) | 2.30138703 |
| 165 | auditory behavior (GO:0031223) | 2.29011685 |
| 166 | reflex (GO:0060004) | 2.28971287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.01499513 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.71635820 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.16456029 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.79182407 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.56453089 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.48784900 |
| 7 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.45295833 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.31451878 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.15851365 |
| 10 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.14426994 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.04863750 |
| 12 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.96663535 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.88258224 |
| 14 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.86224900 |
| 15 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.84895623 |
| 16 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.82481674 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.81824877 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.80759749 |
| 19 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.76229445 |
| 20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.73719223 |
| 21 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.71342116 |
| 22 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.71041766 |
| 23 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.63944633 |
| 24 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60586489 |
| 25 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.60443034 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.56747402 |
| 27 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.55980931 |
| 28 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.55815818 |
| 29 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.54584743 |
| 30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.48315029 |
| 31 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.45818202 |
| 32 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.45499344 |
| 33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.43869610 |
| 34 | EWS_26573619_Chip-Seq_HEK293_Human | 1.42357605 |
| 35 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.41527992 |
| 36 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.41498569 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41483733 |
| 38 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.39245488 |
| 39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.38968827 |
| 40 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.38826375 |
| 41 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.38550351 |
| 42 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.38538418 |
| 43 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.35999732 |
| 44 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.35494289 |
| 45 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.35177491 |
| 46 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.34578166 |
| 47 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33483135 |
| 48 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.32529895 |
| 49 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.31278369 |
| 50 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.29890875 |
| 51 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.29172026 |
| 52 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.28625482 |
| 53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.26714466 |
| 54 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.26101951 |
| 55 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.25944818 |
| 56 | TCF4_23295773_ChIP-Seq_U87_Human | 1.23273656 |
| 57 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.22753463 |
| 58 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.21650502 |
| 59 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.20498964 |
| 60 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20226913 |
| 61 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.18923307 |
| 62 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18078052 |
| 63 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.16846633 |
| 64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16570860 |
| 65 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.16371660 |
| 66 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.16371660 |
| 67 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.14668507 |
| 68 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.13726187 |
| 69 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.11929678 |
| 70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.11815683 |
| 71 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.11684992 |
| 72 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.11196164 |
| 73 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10585588 |
| 74 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10382824 |
| 75 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.10067140 |
| 76 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.09435944 |
| 77 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.09435944 |
| 78 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.08081140 |
| 79 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.07309159 |
| 80 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06131176 |
| 81 | STAT3_23295773_ChIP-Seq_U87_Human | 1.06111144 |
| 82 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.05113023 |
| 83 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04853742 |
| 84 | FUS_26573619_Chip-Seq_HEK293_Human | 1.04654208 |
| 85 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.04178633 |
| 86 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03972372 |
| 87 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.03942428 |
| 88 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.03670915 |
| 89 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.03088383 |
| 90 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03061717 |
| 91 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02070590 |
| 92 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.00890443 |
| 93 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00619601 |
| 94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99967346 |
| 95 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.99769158 |
| 96 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99230474 |
| 97 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.98860546 |
| 98 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.98381318 |
| 99 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98222715 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97805965 |
| 101 | AR_25329375_ChIP-Seq_VCAP_Human | 0.97170712 |
| 102 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.96620078 |
| 103 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96417199 |
| 104 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.96236000 |
| 105 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.96183573 |
| 106 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.95958317 |
| 107 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.95958317 |
| 108 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.95177752 |
| 109 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.95177752 |
| 110 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.93476570 |
| 111 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93123153 |
| 112 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92706417 |
| 113 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.92064594 |
| 114 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.91981541 |
| 115 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91388211 |
| 116 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.91380824 |
| 117 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.90813161 |
| 118 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.90694418 |
| 119 | KDM2B_26808549_Chip-Seq_REH_Human | 0.89906456 |
| 120 | NCOR_22424771_ChIP-Seq_293T_Human | 0.89800825 |
| 121 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.88257771 |
| 122 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.87571902 |
| 123 | JUN_21703547_ChIP-Seq_K562_Human | 0.86936248 |
| 124 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.86477802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.66366051 |
| 2 | MP0004043_abnormal_pH_regulation | 3.51650428 |
| 3 | MP0010386_abnormal_urinary_bladder | 3.44943540 |
| 4 | MP0005645_abnormal_hypothalamus_physiol | 3.44602672 |
| 5 | MP0003195_calcinosis | 3.22895564 |
| 6 | MP0003787_abnormal_imprinting | 3.13276398 |
| 7 | MP0005360_urolithiasis | 2.93984918 |
| 8 | MP0003122_maternal_imprinting | 2.92223756 |
| 9 | MP0006276_abnormal_autonomic_nervous | 2.92002130 |
| 10 | MP0008877_abnormal_DNA_methylation | 2.29319266 |
| 11 | MP0005332_abnormal_amino_acid | 2.26638213 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.21042173 |
| 13 | MP0002638_abnormal_pupillary_reflex | 2.19624814 |
| 14 | MP0001905_abnormal_dopamine_level | 2.07769128 |
| 15 | MP0002909_abnormal_adrenal_gland | 2.07004412 |
| 16 | MP0005365_abnormal_bile_salt | 2.05329153 |
| 17 | MP0005379_endocrine/exocrine_gland_phen | 2.05255413 |
| 18 | MP0002876_abnormal_thyroid_physiology | 2.04606076 |
| 19 | MP0003183_abnormal_peptide_metabolism | 2.03959394 |
| 20 | MP0005084_abnormal_gallbladder_morpholo | 1.99151885 |
| 21 | MP0005535_abnormal_body_temperature | 1.98344918 |
| 22 | MP0001529_abnormal_vocalization | 1.98016295 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 1.96478347 |
| 24 | MP0003011_delayed_dark_adaptation | 1.96080863 |
| 25 | MP0002837_dystrophic_cardiac_calcinosis | 1.89933964 |
| 26 | MP0000538_abnormal_urinary_bladder | 1.85091079 |
| 27 | MP0000013_abnormal_adipose_tissue | 1.84478102 |
| 28 | MP0001765_abnormal_ion_homeostasis | 1.83590045 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 1.83553458 |
| 30 | MP0009046_muscle_twitch | 1.80765876 |
| 31 | MP0005085_abnormal_gallbladder_physiolo | 1.75084843 |
| 32 | MP0001756_abnormal_urination | 1.74566772 |
| 33 | MP0005220_abnormal_exocrine_pancreas | 1.74273216 |
| 34 | MP0003121_genomic_imprinting | 1.73600771 |
| 35 | MP0001501_abnormal_sleep_pattern | 1.73176651 |
| 36 | MP0005636_abnormal_mineral_homeostasis | 1.72512993 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.71799485 |
| 38 | MP0001188_hyperpigmentation | 1.69867380 |
| 39 | MP0002735_abnormal_chemical_nociception | 1.66551584 |
| 40 | MP0002693_abnormal_pancreas_physiology | 1.65001151 |
| 41 | MP0009643_abnormal_urine_homeostasis | 1.64593280 |
| 42 | MP0002734_abnormal_mechanical_nocicepti | 1.62897804 |
| 43 | MP0003123_paternal_imprinting | 1.62746939 |
| 44 | MP0002064_seizures | 1.62345131 |
| 45 | MP0003283_abnormal_digestive_organ | 1.61305196 |
| 46 | MP0002822_catalepsy | 1.59164890 |
| 47 | MP0009745_abnormal_behavioral_response | 1.58706503 |
| 48 | MP0003635_abnormal_synaptic_transmissio | 1.52115341 |
| 49 | MP0001944_abnormal_pancreas_morphology | 1.51982271 |
| 50 | MP0004270_analgesia | 1.51178194 |
| 51 | MP0002733_abnormal_thermal_nociception | 1.50458989 |
| 52 | MP0006072_abnormal_retinal_apoptosis | 1.49607718 |
| 53 | MP0002572_abnormal_emotion/affect_behav | 1.49506558 |
| 54 | MP0002272_abnormal_nervous_system | 1.49137964 |
| 55 | MP0005253_abnormal_eye_physiology | 1.47292803 |
| 56 | MP0005423_abnormal_somatic_nervous | 1.42657730 |
| 57 | MP0003868_abnormal_feces_composition | 1.36644038 |
| 58 | MP0001502_abnormal_circadian_rhythm | 1.36000019 |
| 59 | MP0002078_abnormal_glucose_homeostasis | 1.35936335 |
| 60 | MP0001984_abnormal_olfaction | 1.35395834 |
| 61 | MP0004147_increased_porphyrin_level | 1.32227285 |
| 62 | MP0002163_abnormal_gland_morphology | 1.29925310 |
| 63 | MP0003959_abnormal_lean_body | 1.26578221 |
| 64 | MP0008872_abnormal_physiological_respon | 1.26392378 |
| 65 | MP0001970_abnormal_pain_threshold | 1.25313934 |
| 66 | MP0005058_abnormal_lysosome_morphology | 1.24937493 |
| 67 | MP0010329_abnormal_lipoprotein_level | 1.24511459 |
| 68 | MP0004885_abnormal_endolymph | 1.24426505 |
| 69 | MP0001764_abnormal_homeostasis | 1.24028083 |
| 70 | MP0001440_abnormal_grooming_behavior | 1.22662374 |
| 71 | MP0003880_abnormal_central_pattern | 1.22567448 |
| 72 | MP0002751_abnormal_autonomic_nervous | 1.21738285 |
| 73 | MP0002063_abnormal_learning/memory/cond | 1.21652268 |
| 74 | MP0004142_abnormal_muscle_tone | 1.18185711 |
| 75 | MP0004924_abnormal_behavior | 1.18151101 |
| 76 | MP0005386_behavior/neurological_phenoty | 1.18151101 |
| 77 | MP0002184_abnormal_innervation | 1.16626106 |
| 78 | MP0005551_abnormal_eye_electrophysiolog | 1.15197290 |
| 79 | MP0006036_abnormal_mitochondrial_physio | 1.14888609 |
| 80 | MP0001968_abnormal_touch/_nociception | 1.13899344 |
| 81 | MP0002557_abnormal_social/conspecific_i | 1.13298555 |
| 82 | MP0003953_abnormal_hormone_level | 1.12124323 |
| 83 | MP0003879_abnormal_hair_cell | 1.11733030 |
| 84 | MP0002067_abnormal_sensory_capabilities | 1.11532374 |
| 85 | MP0002160_abnormal_reproductive_system | 1.09780713 |
| 86 | MP0005448_abnormal_energy_balance | 1.07827359 |
| 87 | MP0005083_abnormal_biliary_tract | 1.02923810 |
| 88 | MP0009379_abnormal_foot_pigmentation | 1.00404464 |
| 89 | MP0000230_abnormal_systemic_arterial | 1.00088314 |
| 90 | MP0006292_abnormal_olfactory_placode | 0.99088846 |
| 91 | MP0002069_abnormal_eating/drinking_beha | 0.96909675 |
| 92 | MP0000631_abnormal_neuroendocrine_gland | 0.96639216 |
| 93 | MP0005408_hypopigmentation | 0.96507492 |
| 94 | MP0001986_abnormal_taste_sensitivity | 0.95123773 |
| 95 | MP0002928_abnormal_bile_duct | 0.94810056 |
| 96 | MP0004859_abnormal_synaptic_plasticity | 0.94644696 |
| 97 | MP0008995_early_reproductive_senescence | 0.94493169 |
| 98 | MP0002938_white_spotting | 0.94291987 |
| 99 | MP0006035_abnormal_mitochondrial_morpho | 0.92848295 |
| 100 | MP0003806_abnormal_nucleotide_metabolis | 0.90495289 |
| 101 | MP0002229_neurodegeneration | 0.90330911 |
| 102 | MP0002736_abnormal_nociception_after | 0.89859402 |
| 103 | MP0001664_abnormal_digestion | 0.89766215 |
| 104 | MP0003252_abnormal_bile_duct | 0.89559652 |
| 105 | MP0009780_abnormal_chondrocyte_physiolo | 0.88215482 |
| 106 | MP0004133_heterotaxia | 0.87572722 |
| 107 | MP0001666_abnormal_nutrient_absorption | 0.87361702 |
| 108 | MP0004215_abnormal_myocardial_fiber | 0.86973133 |
| 109 | MP0004085_abnormal_heartbeat | 0.84177356 |
| 110 | MP0010234_abnormal_vibrissa_follicle | 0.79096893 |
| 111 | MP0001485_abnormal_pinna_reflex | 0.78810315 |
| 112 | MP0002882_abnormal_neuron_morphology | 0.78583661 |
| 113 | MP0005389_reproductive_system_phenotype | 0.78059185 |
| 114 | MP0008961_abnormal_basal_metabolism | 0.77096435 |
| 115 | MP0002066_abnormal_motor_capabilities/c | 0.77093621 |
| 116 | MP0003633_abnormal_nervous_system | 0.75066754 |
| 117 | MP0002090_abnormal_vision | 0.74663933 |
| 118 | MP0000639_abnormal_adrenal_gland | 0.74331245 |
| 119 | MP0001486_abnormal_startle_reflex | 0.71690625 |
| 120 | MP0002118_abnormal_lipid_homeostasis | 0.71633327 |
| 121 | MP0002136_abnormal_kidney_physiology | 0.68089488 |
| 122 | MP0004742_abnormal_vestibular_system | 0.68070815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gout (HP:0001997) | 4.51934909 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.32579844 |
| 3 | Pheochromocytoma (HP:0002666) | 4.22822189 |
| 4 | Hypothermia (HP:0002045) | 4.12068716 |
| 5 | Neuroendocrine neoplasm (HP:0100634) | 3.93590263 |
| 6 | Retinal atrophy (HP:0001105) | 3.69540817 |
| 7 | Increased circulating renin level (HP:0000848) | 3.64542748 |
| 8 | Hyperactive renin-angiotensin system (HP:0000841) | 3.63821728 |
| 9 | Ketoacidosis (HP:0001993) | 3.58281746 |
| 10 | Acute necrotizing encephalopathy (HP:0006965) | 3.53710904 |
| 11 | Hypomagnesemia (HP:0002917) | 3.48264533 |
| 12 | Acute encephalopathy (HP:0006846) | 3.45944300 |
| 13 | Limb dystonia (HP:0002451) | 3.43167661 |
| 14 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.34547253 |
| 15 | Large for gestational age (HP:0001520) | 3.28343573 |
| 16 | Hypokalemic alkalosis (HP:0001949) | 3.27048626 |
| 17 | Abnormality of chloride homeostasis (HP:0011422) | 3.24061186 |
| 18 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.13682834 |
| 19 | Increased hepatocellular lipid droplets (HP:0006565) | 3.13061997 |
| 20 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.09546669 |
| 21 | Metabolic alkalosis (HP:0200114) | 3.07671995 |
| 22 | Abnormality of magnesium homeostasis (HP:0004921) | 3.07139867 |
| 23 | Polyuria (HP:0000103) | 3.01336713 |
| 24 | Progressive macrocephaly (HP:0004481) | 2.97325568 |
| 25 | Ketosis (HP:0001946) | 2.90475051 |
| 26 | Hypoglycemic seizures (HP:0002173) | 2.89512267 |
| 27 | Hypoglycemic coma (HP:0001325) | 2.87842646 |
| 28 | Abnormality of renin-angiotensin system (HP:0000847) | 2.87083472 |
| 29 | Symptomatic seizures (HP:0011145) | 2.83019437 |
| 30 | Abnormal urine output (HP:0012590) | 2.80837626 |
| 31 | Methylmalonic acidemia (HP:0002912) | 2.80037183 |
| 32 | Mitochondrial inheritance (HP:0001427) | 2.77886531 |
| 33 | Cerebral edema (HP:0002181) | 2.76646182 |
| 34 | Proximal tubulopathy (HP:0000114) | 2.74789469 |
| 35 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.73484127 |
| 36 | Alkalosis (HP:0001948) | 2.70773809 |
| 37 | Hyperglycemia (HP:0003074) | 2.69716487 |
| 38 | Glycosuria (HP:0003076) | 2.69420335 |
| 39 | Abnormality of urine glucose concentration (HP:0011016) | 2.69420335 |
| 40 | Abnormality of renal excretion (HP:0011036) | 2.68189680 |
| 41 | Abnormal drinking behavior (HP:0030082) | 2.67325716 |
| 42 | Polydipsia (HP:0001959) | 2.67325716 |
| 43 | Renal Fanconi syndrome (HP:0001994) | 2.65548657 |
| 44 | Generalized aminoaciduria (HP:0002909) | 2.64228015 |
| 45 | Febrile seizures (HP:0002373) | 2.63923886 |
| 46 | Hyperaldosteronism (HP:0000859) | 2.61590661 |
| 47 | Hyperglycinuria (HP:0003108) | 2.61361116 |
| 48 | Abnormality of midbrain morphology (HP:0002418) | 2.60714046 |
| 49 | Molar tooth sign on MRI (HP:0002419) | 2.60714046 |
| 50 | Hemiparesis (HP:0001269) | 2.60040632 |
| 51 | Hyperphosphaturia (HP:0003109) | 2.56689575 |
| 52 | Abnormal pupillary function (HP:0007686) | 2.55855297 |
| 53 | Intestinal atresia (HP:0011100) | 2.54200708 |
| 54 | Hyperuricemia (HP:0002149) | 2.53310007 |
| 55 | Increased purine levels (HP:0004368) | 2.53310007 |
| 56 | Hypokalemia (HP:0002900) | 2.52360438 |
| 57 | Abnormality of vitamin B metabolism (HP:0004340) | 2.51251838 |
| 58 | Double outlet right ventricle (HP:0001719) | 2.49269820 |
| 59 | Congenital malformation of the right heart (HP:0011723) | 2.49269820 |
| 60 | Polyphagia (HP:0002591) | 2.48283765 |
| 61 | Medial flaring of the eyebrow (HP:0010747) | 2.47922043 |
| 62 | Abnormality of purine metabolism (HP:0004352) | 2.46640231 |
| 63 | Hepatic necrosis (HP:0002605) | 2.44207064 |
| 64 | Gait imbalance (HP:0002141) | 2.43385991 |
| 65 | Tetany (HP:0001281) | 2.43246510 |
| 66 | Increased CSF lactate (HP:0002490) | 2.42525600 |
| 67 | Renal cortical cysts (HP:0000803) | 2.42299739 |
| 68 | Pancreatic fibrosis (HP:0100732) | 2.41910241 |
| 69 | Myokymia (HP:0002411) | 2.41723026 |
| 70 | Congenital primary aphakia (HP:0007707) | 2.40481412 |
| 71 | Agitation (HP:0000713) | 2.40126154 |
| 72 | Poor suck (HP:0002033) | 2.39693805 |
| 73 | Muscular hypotonia of the trunk (HP:0008936) | 2.39430061 |
| 74 | Nephrogenic diabetes insipidus (HP:0009806) | 2.39322894 |
| 75 | 3-Methylglutaconic aciduria (HP:0003535) | 2.38939328 |
| 76 | Hypokinesia (HP:0002375) | 2.36953899 |
| 77 | Abnormality of renal resorption (HP:0011038) | 2.36018953 |
| 78 | Decreased circulating renin level (HP:0003351) | 2.35233382 |
| 79 | Absence seizures (HP:0002121) | 2.34003446 |
| 80 | Retinal dysplasia (HP:0007973) | 2.32033615 |
| 81 | Oligomenorrhea (HP:0000876) | 2.31143890 |
| 82 | Hepatocellular necrosis (HP:0001404) | 2.29371113 |
| 83 | Dialeptic seizures (HP:0011146) | 2.28815596 |
| 84 | Gaze-evoked nystagmus (HP:0000640) | 2.27984611 |
| 85 | Diminished movement (HP:0002374) | 2.27773426 |
| 86 | Hyperthyroidism (HP:0000836) | 2.26683137 |
| 87 | Abnormality of the renal cortex (HP:0011035) | 2.25497042 |
| 88 | Nephronophthisis (HP:0000090) | 2.24084758 |
| 89 | Methylmalonic aciduria (HP:0012120) | 2.22517402 |
| 90 | Epileptic encephalopathy (HP:0200134) | 2.22094887 |
| 91 | Focal seizures (HP:0007359) | 2.20643192 |
| 92 | Abnormal urine phosphate concentration (HP:0012599) | 2.20173306 |
| 93 | Focal motor seizures (HP:0011153) | 2.19674768 |
| 94 | True hermaphroditism (HP:0010459) | 2.16794847 |
| 95 | Conjugated hyperbilirubinemia (HP:0002908) | 2.15768127 |
| 96 | Late onset (HP:0003584) | 2.14296089 |
| 97 | Lethargy (HP:0001254) | 2.14118388 |
| 98 | Failure to thrive in infancy (HP:0001531) | 2.13577285 |
| 99 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.12848329 |
| 100 | Renal salt wasting (HP:0000127) | 2.12828950 |
| 101 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.12195318 |
| 102 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.12195318 |
| 103 | Abnormality of potassium homeostasis (HP:0011042) | 2.11185153 |
| 104 | Anxiety (HP:0000739) | 2.10470745 |
| 105 | Type II lissencephaly (HP:0007260) | 2.09764172 |
| 106 | Enlarged kidneys (HP:0000105) | 2.08670758 |
| 107 | Generalized tonic-clonic seizures (HP:0002069) | 2.06738659 |
| 108 | Limb hypertonia (HP:0002509) | 2.06738641 |
| 109 | Abnormality of glycine metabolism (HP:0010895) | 2.03586584 |
| 110 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.03586584 |
| 111 | Hyperglycinemia (HP:0002154) | 2.03300682 |
| 112 | Occipital encephalocele (HP:0002085) | 2.01206309 |
| 113 | Respiratory failure (HP:0002878) | 2.01083565 |
| 114 | Abnormality of vitamin metabolism (HP:0100508) | 2.00956037 |
| 115 | Lactic acidosis (HP:0003128) | 2.00358808 |
| 116 | EEG with generalized epileptiform discharges (HP:0011198) | 1.99504108 |
| 117 | Increased intramyocellular lipid droplets (HP:0012240) | 1.98909746 |
| 118 | Hypophosphatemia (HP:0002148) | 1.98002883 |
| 119 | Progressive cerebellar ataxia (HP:0002073) | 1.95642986 |
| 120 | Hypotension (HP:0002615) | 1.95407618 |
| 121 | Neoplasm of the adrenal gland (HP:0100631) | 1.94863511 |
| 122 | Congenital stationary night blindness (HP:0007642) | 1.92920294 |
| 123 | Furrowed tongue (HP:0000221) | 1.92617003 |
| 124 | Epileptiform EEG discharges (HP:0011182) | 1.92148176 |
| 125 | Atonic seizures (HP:0010819) | 1.91565140 |
| 126 | Vacuolated lymphocytes (HP:0001922) | 1.91038644 |
| 127 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.90725343 |
| 128 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.90725343 |
| 129 | Akinesia (HP:0002304) | 1.89312086 |
| 130 | Irritability (HP:0000737) | 1.89236878 |
| 131 | Tachypnea (HP:0002789) | 1.88203887 |
| 132 | Pancreatic cysts (HP:0001737) | 1.87453578 |
| 133 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.87108643 |
| 134 | Postural tremor (HP:0002174) | 1.86732380 |
| 135 | Hypsarrhythmia (HP:0002521) | 1.86468177 |
| 136 | Vomiting (HP:0002013) | 1.85196783 |
| 137 | Adrenal overactivity (HP:0002717) | 1.84771947 |
| 138 | Exertional dyspnea (HP:0002875) | 1.82984158 |
| 139 | Hepatoblastoma (HP:0002884) | 1.82805574 |
| 140 | Vaginal atresia (HP:0000148) | 1.82354438 |
| 141 | Increased serum lactate (HP:0002151) | 1.80823119 |
| 142 | Metabolic acidosis (HP:0001942) | 1.80395899 |
| 143 | Cerebellar dysplasia (HP:0007033) | 1.79977589 |
| 144 | Genital tract atresia (HP:0001827) | 1.79343893 |
| 145 | Abnormality of the renal medulla (HP:0100957) | 1.78698391 |
| 146 | Dysautonomia (HP:0002459) | 1.78682881 |
| 147 | Abnormality of the corticospinal tract (HP:0002492) | 1.77932414 |
| 148 | Optic disc pallor (HP:0000543) | 1.77662707 |
| 149 | Lipid accumulation in hepatocytes (HP:0006561) | 1.77570974 |
| 150 | Fetal akinesia sequence (HP:0001989) | 1.75035006 |
| 151 | Abnormal eating behavior (HP:0100738) | 1.74710426 |
| 152 | Progressive inability to walk (HP:0002505) | 1.74269279 |
| 153 | Sex reversal (HP:0012245) | 1.74250538 |
| 154 | Abnormal sex determination (HP:0012244) | 1.74250538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 7.18029265 |
| 2 | WNK4 | 4.47025897 |
| 3 | MAPK15 | 2.96839952 |
| 4 | INSRR | 2.91761394 |
| 5 | OXSR1 | 2.80341974 |
| 6 | PNCK | 2.50399467 |
| 7 | MAP4K2 | 2.39998334 |
| 8 | DAPK2 | 2.20795706 |
| 9 | BCKDK | 2.15486676 |
| 10 | CSNK1G3 | 2.12760850 |
| 11 | FRK | 2.01936590 |
| 12 | MAP2K7 | 1.98431138 |
| 13 | FGFR2 | 1.92523177 |
| 14 | MST4 | 1.91340160 |
| 15 | PRPF4B | 1.89535528 |
| 16 | MAP3K12 | 1.82666438 |
| 17 | NTRK3 | 1.81988404 |
| 18 | STK16 | 1.80275120 |
| 19 | MAP3K4 | 1.80031499 |
| 20 | STK39 | 1.70051833 |
| 21 | GRK7 | 1.67470102 |
| 22 | CSNK1G2 | 1.63135511 |
| 23 | CASK | 1.59962672 |
| 24 | CSNK1G1 | 1.55734303 |
| 25 | NME1 | 1.49205881 |
| 26 | PIK3CG | 1.49015750 |
| 27 | MAP3K2 | 1.46630071 |
| 28 | GRK5 | 1.41767984 |
| 29 | CAMKK2 | 1.41099476 |
| 30 | ARAF | 1.31973386 |
| 31 | MAP2K4 | 1.31072935 |
| 32 | MAP3K9 | 1.27141229 |
| 33 | SGK494 | 1.15318136 |
| 34 | SGK223 | 1.15318136 |
| 35 | NTRK1 | 1.13636268 |
| 36 | ACVR1B | 1.13002209 |
| 37 | PRKD3 | 1.12627500 |
| 38 | PAK3 | 1.11762410 |
| 39 | IRAK1 | 1.11389399 |
| 40 | MINK1 | 1.11245896 |
| 41 | UHMK1 | 1.08098800 |
| 42 | DYRK2 | 1.07973284 |
| 43 | CSNK1A1L | 1.07022291 |
| 44 | MARK1 | 1.05751827 |
| 45 | STK38L | 1.04633764 |
| 46 | MAP2K6 | 1.00394259 |
| 47 | FGFR4 | 0.98671904 |
| 48 | BMPR1B | 0.96476629 |
| 49 | PINK1 | 0.93540050 |
| 50 | BCR | 0.93146378 |
| 51 | WNK1 | 0.92634178 |
| 52 | NTRK2 | 0.92014956 |
| 53 | ERBB4 | 0.89886145 |
| 54 | TRPM7 | 0.86848108 |
| 55 | TRIM28 | 0.86431736 |
| 56 | CAMK2G | 0.82445100 |
| 57 | MUSK | 0.82161666 |
| 58 | PRKCE | 0.82023520 |
| 59 | PRKCG | 0.80285723 |
| 60 | HIPK2 | 0.78602410 |
| 61 | TAOK3 | 0.78336900 |
| 62 | ADRBK2 | 0.77891668 |
| 63 | IRAK3 | 0.77244785 |
| 64 | SGK2 | 0.76358814 |
| 65 | PRKCI | 0.76195274 |
| 66 | CAMK2A | 0.75337527 |
| 67 | TLK1 | 0.74885710 |
| 68 | ZAK | 0.73785870 |
| 69 | FER | 0.72331242 |
| 70 | PLK2 | 0.68859402 |
| 71 | AKT3 | 0.68224448 |
| 72 | BMPR2 | 0.66496568 |
| 73 | DAPK1 | 0.65926650 |
| 74 | FES | 0.64370309 |
| 75 | ADRBK1 | 0.63278381 |
| 76 | IRAK2 | 0.62375624 |
| 77 | TIE1 | 0.60084693 |
| 78 | FGFR3 | 0.59771890 |
| 79 | CAMK1G | 0.59754377 |
| 80 | EPHA3 | 0.58503030 |
| 81 | MAPK13 | 0.58461560 |
| 82 | CAMK2D | 0.57753218 |
| 83 | CSNK1E | 0.56615460 |
| 84 | BRAF | 0.54384070 |
| 85 | PRKACA | 0.54306583 |
| 86 | NUAK1 | 0.53368800 |
| 87 | LIMK1 | 0.53173705 |
| 88 | MAP3K1 | 0.52893150 |
| 89 | CSNK1A1 | 0.51751008 |
| 90 | GRK1 | 0.51574684 |
| 91 | DYRK1A | 0.50930651 |
| 92 | PRKACB | 0.49473033 |
| 93 | ERBB3 | 0.48828296 |
| 94 | STK11 | 0.47475198 |
| 95 | MAPKAPK5 | 0.46743556 |
| 96 | CAMK2B | 0.46429775 |
| 97 | PASK | 0.46341469 |
| 98 | MAP3K3 | 0.45703940 |
| 99 | CAMK1 | 0.45444139 |
| 100 | MYLK | 0.44926198 |
| 101 | PDK2 | 0.44437555 |
| 102 | SCYL2 | 0.43708990 |
| 103 | PRKACG | 0.43621226 |
| 104 | PRKAA1 | 0.41625004 |
| 105 | TNIK | 0.40902039 |
| 106 | TNK2 | 0.40705646 |
| 107 | PRKCH | 0.40325054 |
| 108 | PRKCZ | 0.40142784 |
| 109 | CSNK1D | 0.39036617 |
| 110 | CDK5 | 0.38749094 |
| 111 | SGK1 | 0.38748724 |
| 112 | PAK6 | 0.38269461 |
| 113 | PLK3 | 0.38041492 |
| 114 | LATS1 | 0.38012400 |
| 115 | RPS6KA5 | 0.35362632 |
| 116 | EIF2AK3 | 0.34837015 |
| 117 | EIF2AK1 | 0.34559549 |
| 118 | CAMKK1 | 0.34294806 |
| 119 | EPHA4 | 0.34190859 |
| 120 | NLK | 0.34026429 |
| 121 | CDC42BPA | 0.32710884 |
| 122 | PHKG2 | 0.31804603 |
| 123 | PHKG1 | 0.31804603 |
| 124 | PRKCA | 0.31676697 |
| 125 | TSSK6 | 0.31288569 |
| 126 | STK38 | 0.31007811 |
| 127 | RPS6KB1 | 0.30864568 |
| 128 | MAP2K1 | 0.29768241 |
| 129 | PRKG1 | 0.29316000 |
| 130 | DYRK1B | 0.28654736 |
| 131 | PDK3 | 0.27946457 |
| 132 | PDK4 | 0.27946457 |
| 133 | CSNK2A2 | 0.27740956 |
| 134 | KSR1 | 0.26074176 |
| 135 | SGK3 | 0.25566797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.76723548 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.41407361 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.26738342 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.15935674 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.96450173 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.63173767 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.49209413 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.29225530 |
| 9 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.18088352 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.17006889 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.05708435 |
| 12 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.04752175 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.87897315 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.80479320 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 1.77031740 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.74473456 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.72786586 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.66765609 |
| 19 | Huntingtons disease_Homo sapiens_hsa05016 | 1.60731271 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.58170520 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.56251310 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.56075986 |
| 23 | Cocaine addiction_Homo sapiens_hsa05030 | 1.56020686 |
| 24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.55853720 |
| 25 | Insulin secretion_Homo sapiens_hsa04911 | 1.55851271 |
| 26 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.47595578 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.42397174 |
| 28 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.40354222 |
| 29 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.39936184 |
| 30 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.33256658 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.30530830 |
| 32 | GABAergic synapse_Homo sapiens_hsa04727 | 1.27582409 |
| 33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.25338191 |
| 34 | Nicotine addiction_Homo sapiens_hsa05033 | 1.23739918 |
| 35 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.14582152 |
| 36 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.13335968 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13021332 |
| 38 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.12838481 |
| 39 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.12045601 |
| 40 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.08098739 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.07917255 |
| 42 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.07865905 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.07203630 |
| 44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.04759429 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.02598631 |
| 46 | Taste transduction_Homo sapiens_hsa04742 | 1.02038041 |
| 47 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.01056370 |
| 48 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.99021411 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.97874350 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97445796 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.96513026 |
| 52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.96180786 |
| 53 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.95069517 |
| 54 | Basal transcription factors_Homo sapiens_hsa03022 | 0.93689777 |
| 55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.93328579 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.92427248 |
| 57 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.88307909 |
| 58 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.87842812 |
| 59 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.87334541 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.85075286 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82481101 |
| 62 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.78808934 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78571386 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.78078241 |
| 65 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.75138865 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72296295 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.70697951 |
| 68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.70644700 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70603073 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70166399 |
| 71 | Retinol metabolism_Homo sapiens_hsa00830 | 0.70019112 |
| 72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.69779486 |
| 73 | RNA polymerase_Homo sapiens_hsa03020 | 0.69583672 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69324743 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.69158686 |
| 76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.67733808 |
| 77 | Morphine addiction_Homo sapiens_hsa05032 | 0.67442547 |
| 78 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.66372209 |
| 79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.66304510 |
| 80 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.65025177 |
| 81 | Proteasome_Homo sapiens_hsa03050 | 0.64559114 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.63833571 |
| 83 | Salivary secretion_Homo sapiens_hsa04970 | 0.63463130 |
| 84 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61612082 |
| 85 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61078255 |
| 86 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.61059018 |
| 87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60850831 |
| 88 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.60833811 |
| 89 | Circadian entrainment_Homo sapiens_hsa04713 | 0.60728727 |
| 90 | Carbon metabolism_Homo sapiens_hsa01200 | 0.59939923 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58327811 |
| 92 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54811719 |
| 93 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.54750089 |
| 94 | Phototransduction_Homo sapiens_hsa04744 | 0.53849519 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52424243 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52191053 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.51949461 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51787151 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51762623 |
| 100 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.51457358 |
| 101 | Olfactory transduction_Homo sapiens_hsa04740 | 0.50419192 |
| 102 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.50167187 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50025267 |
| 104 | Bile secretion_Homo sapiens_hsa04976 | 0.49899406 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.49645777 |
| 106 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.48404184 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.45841771 |
| 108 | Renin secretion_Homo sapiens_hsa04924 | 0.45260231 |
| 109 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44177918 |
| 110 | RNA degradation_Homo sapiens_hsa03018 | 0.43964928 |
| 111 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43667613 |
| 112 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.43533875 |
| 113 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43260053 |
| 114 | Purine metabolism_Homo sapiens_hsa00230 | 0.42583002 |
| 115 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.41335664 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.40001260 |
| 117 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.39577808 |
| 118 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.39396854 |
| 119 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.36502616 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.34521891 |
| 121 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32495972 |
| 122 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31181012 |
| 123 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.31083500 |
| 124 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.30707513 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30633708 |
| 126 | Long-term depression_Homo sapiens_hsa04730 | 0.29415497 |
| 127 | Circadian rhythm_Homo sapiens_hsa04710 | 0.29247309 |

